Mycobacterium chelonae, an ‘atypical’ cause of an LVAD driveline infection

Akin, 2018, 18F-FDG PET/CT in the diagnosis and management of continuous flow left ventricular assist device infections: a case series and review of the literature, Asaio J, 64, e11, 10.1097/MAT.0000000000000552 Balsam, 2017, Mycobacterium chimaera left ventricular assist device infections, J Card Surg, 32, 402, 10.1111/jocs.13150 de By, 2018, The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report, Eur J Cardiothorac Surg, 53, 309, 10.1093/ejcts/ezx320 Griffith, 2007, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, 175, 367, 10.1164/rccm.200604-571ST Kormos, 2019, The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships, J Heart Lung Transplant, 38, 114, 10.1016/j.healun.2018.11.013 Kusne, 2017, An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection, J Heart Lung Transplant, 36, 1137, 10.1016/j.healun.2017.06.007 Nienaber, 2013, Clinical manifestations and management of left ventricular assist device-associated infections, Clin Infect Dis, 57, 1438, 10.1093/cid/cit536 Nunez Breton, 2018, Mycobacterium abscessus left ventricle assist device driveline infections: an emerging pathogen?, Transpl Infect Dis, 20, 10.1111/tid.12957 Simeon, 2017, Left ventricular assist device-related infections: a multicentric study, Clin Microbiol Infect, 23, 748, 10.1016/j.cmi.2017.03.008 Sousa, 2015, Nontuberculous mycobacteria pathogenesis and biofilm assembly, Int J Mycobacteriol, 4, 36, 10.1016/j.ijmyco.2014.11.065